Helvetic BioPharma is an innovative bio-pharmaceutical company based in Ticino, Switzerland.
Our activities are based on research, development, production and marketing of pharmaceutical products in the fields of Oncology and Urology.
The technologies platforms we use include recombinant proteins biopharmaceutical, synthetic peptides and microsphere-based drugs for slow release formulation.
Helvetic Bio Pharma has a strategic and customer-focused approach to developing, producing and marketing high-quality affordable medicines.
Our worldwide commercial presence relies on the many partners for the promotion of our portfolio.